How Many Opioids Have Received ADP Designation on the Basis of Category 1 Studies Alone?

J. David Haddox, DDS, MD, corrects a misconception about opioids with abuse-deterrent properties.

J. David Haddox, DDS, MD, corrects a misconception about opioids with abuse-deterrent properties.

Related Content:

ConferenceRetail
Investigators Identify Characteristics to Better Define Long COVID
Case Studies: May 2022
Generic Product News: May 2022